ClinConnect ClinConnect Logo
Search / Trial NCT03851458

Consumption of More Ideal Food Options (COMIDA: Consumo de Opciones Más Ideales De Alimentos)

Launched by MEMORIAL SLOAN KETTERING CANCER CENTER · Feb 20, 2019

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Focus Groups 15 088

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • For COMIDA participants only:
  • Self-Identifies as Mexican American or Mexican
  • Seeking services at the VDS of the Mexican Consulate
  • Prefers to speak in Spanish
  • All adults at least 18 years of age
  • Screens as obese (an adult who has a Body Mass Index (BMI) 30 or higher) or overweight (an adult who has a BMI between 25 - 29.9)
  • Agrees to be audio recorded
  • For SANOS focus group participants only:
  • Self-identifies as Hispanic/Latino;
  • Seeking services at VDS or VDS Mobile;
  • Prefers to speak in Spanish;
  • At least 18 years of age;
  • Screens as obese (BMI ≥ 30 kg/m\^2) or overweight (BMI of 25 - 29.9 kg/m\^2);
  • Agrees to be audio recorded
  • For SANOS RCT participants only:
  • Self-identifies as Hispanic/Latino;
  • Seeking services at VDS or VDS Mobile;
  • Prefers to speak in Spanish;
  • At least 18 years of age;
  • Screens as obese (BMI ≥ 30 kg/m\^2) or overweight (BMI of 25 - 29.9 kg/m\^2);
  • Owns a cell phone capable of receiving text messages;
  • Agrees to be audio recorded
  • For Family COMIDA participants only:
  • Self-Identifies as Hispanic/Latino
  • Seeking services at the VDS (or has used VDS services in the past) of the Mexican Consulate or VDS Mobile
  • Prefers to speak in Spanish
  • At least 18 years of age
  • Has at least one child under age 18 living in the same household
  • Owns a cell phone capable of receiving text messages
  • Willing to receive text messages (3 texts per week for 3 months)
  • Owns an internet connected device (eg, cell phone, tablet, etc) capable of conducting teleconference calls (eg, Zoom)
  • For ROADmAP RCT participants only:
  • At least 21 years of age
  • Full-time (drives at least 35 hours per week) licensed taxi/FHV driver
  • Driver for at least 6 months
  • Seeking Health Fairs (or has used Health Fairs services in the past)
  • Speaks English, French, Bengali, or Spanish
  • Screens a as obese (BMI ≥ 30 kg/m2 \[≥25 kg/m2 for South Asians\]) or overweight (BMI of 25 - 29.9 kg/m2 s \[23- 24.9 kg/m2 for South Asians\])
  • (BMI cut-offs are lower for South Asians, per WHO and American Diabetes Association recommendations)
  • Owns a cell phone capable of receiving text messages
  • Agrees to be audio-recorded
  • For ROADmAP Phase 2 participants only:
  • At least 21 years of age
  • Driver who participated in ROADmAP RCT or manager at a taxi garage, Uber, Lyft or driver serving/union/organization
  • Agrees to be audio-recorded
  • Exclusion Criteria:
  • For COMIDA participants only:
  • Will not be in the NYC area for the study duration (3-4 months) Is pregnant or might be pregnant
  • Lactating women
  • Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (Individuals with diabetes, lactose intolerance, and high blood pressure MAY still participate in the study)
  • Has dietary restrictions (i.e. liquid diet)
  • Does not have a phone that accepts text messages or unwilling to accept text messages
  • Presence of a serious psychiatric or cognitive impairment likely to preclude meaningful informed consent and adherence to the protocol per the consenting professional"s judgment
  • Has another family member already enrolled in COMIDA (as determined by patient report)
  • For SANOS focus group participants only:
  • Is pregnant or might be pregnant; lactating women;
  • Self-reported presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with HTN and DM may still participate);
  • Has dietary restrictions (i.e. liquid diet);
  • Has a household member who has already participated (or agreed to participate);
  • For SANOS RCT participants only:
  • Is pregnant or might be pregnant; lactating women; for the study duration (6 months)
  • Self-reported presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with HTN and DM may still participate); restricting diet;
  • Currently has dietary restrictions (i.e. liquid diet);
  • Has a household member who has already participated (or agreed to participate);
  • Has already participated in the study
  • Will not be in the NY Metropolitan area for the study duration (6 months) Works for or with the Mexican consulate (including employment and/or collaborative or volunteer services)
  • For Family COMIDA participants only:
  • Is pregnant or might be pregnant; lactating women for the study duration (3 months)
  • Will not be in the NY Metropolitan area for the study duration (3 months) Presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (Individuals with diabetes, lactose intolerance, and high blood pressure MAY still participate in the study)
  • Has dietary restrictions (i.e. liquid diet)
  • Has another family member who has already participated in COMIDA or SANOS
  • Has already participated in the study
  • Works for or with the Mexican consulate (including employment and/or collaborative or volunteer services)
  • For ROADmAP RCT participants only:
  • Is pregnant or might be pregnant; lactating women; for the study duration (12 months)
  • Self-reported presence of a chronic disease such as cancer, kidney disease, liver disease, etc. (individuals with HTN and DM may still participate) that may restrict diet
  • Currently has dietary restrictions (i.e. liquid diet)
  • Has a household member who has already participated (or agreed to participate)
  • Has already participated in the study
  • Will not be in the NY Metropolitan area for 6 months from study enrollment

About Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSKCC) is a world-renowned institution dedicated to cancer treatment, research, and education. As a leading clinical trial sponsor, MSKCC focuses on advancing innovative cancer therapies through rigorous scientific investigation and collaboration. The center's multidisciplinary team of experts employs cutting-edge methodologies to design and conduct trials that aim to improve patient outcomes and enhance understanding of cancer biology. With a commitment to translating research findings into clinical practice, MSKCC plays a pivotal role in shaping the future of oncology care and ensuring that patients have access to the latest therapeutic advancements.

Locations

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Jennifer Leng, MD, MPH

Principal Investigator

Memorial Sloan Kettering Cancer Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials